Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 20, Issue 37, Pages 13493
Publisher
Baishideng Publishing Group Inc.
Online
2014-10-07
DOI
10.3748/wjg.v20.i37.13493
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SREBP-1c overexpression induces triglycerides accumulation through increasing lipid synthesis and decreasing lipid oxidation and VLDL assembly in bovine hepatocytes
- (2014) Xinwei Li et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study
- (2014) Xian-Feng Lin et al. MOLECULAR BIOLOGY REPORTS
- Nonalcoholic Fatty Liver Disease Is Associated with Aortic Valve Sclerosis in Patients with Type 2 Diabetes Mellitus
- (2014) Stefano Bonapace et al. PLoS One
- Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments
- (2013) R. Kwok et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Activation of farnesoid X receptor induces RECK expression in mouse liver
- (2013) Xiaomin Peng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease
- (2013) Weibin Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Bile acid receptors in non-alcoholic fatty liver disease
- (2013) Yuanyuan Li et al. BIOCHEMICAL PHARMACOLOGY
- Dysregulated Bile Acid Synthesis, Metabolism and Excretion in a High Fat-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats
- (2013) Xiaofang Jia et al. DIGESTIVE DISEASES AND SCIENCES
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice
- (2013) Yan Lu et al. GUT
- Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor-controlled lipid homeostasis
- (2013) Jiesi Xu et al. HEPATOLOGY
- Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.
- (2013) Robert J. Wong et al. HEPATOLOGY
- Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease
- (2013) Rachel H. McMahan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice
- (2013) Xuelian Xiong et al. JOURNAL OF HEPATOLOGY
- Chronic cholestatic liver diseases: Clues from histopathology for pathogenesis
- (2013) Marion J. Pollheimer et al. MOLECULAR ASPECTS OF MEDICINE
- Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance
- (2013) Yongjie Ma et al. PHARMACEUTICAL RESEARCH
- FXR ligands protect against hepatocellular inflammation via SOCS3 induction
- (2012) Zhizhen Xu et al. CELLULAR SIGNALLING
- Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
- (2012) Lokpal S. Bhatia et al. EUROPEAN HEART JOURNAL
- Farnesoid X Receptor Protects Hepatocytes From Injury by Repressing miR-199a-3p, Which Increases Levels of LKB1
- (2012) Chan Gyu Lee et al. GASTROENTEROLOGY
- Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in mice
- (2012) Lisheng Zhang et al. HEPATOLOGY
- Activation of the Farnesoid X Receptor Induces Hepatic Expression and Secretion of Fibroblast Growth Factor 21
- (2012) Holly A. Cyphert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease
- (2012) Kyoko Nomura et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Farnesoid X Receptor Induces Murine Scavenger Receptor Class B Type I via Intron Binding
- (2012) Guodong Li et al. PLoS One
- Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
- (2012) Giovanni Musso et al. PROGRESS IN LIPID RESEARCH
- Fibroblast Growth Factor 21: A Novel Metabolic Regulator
- (2012) Ji A Seo et al. Diabetes & Metabolism Journal
- Bile Acids Induce Inflammatory Genes in Hepatocytes
- (2011) Katryn Allen et al. AMERICAN JOURNAL OF PATHOLOGY
- Soluble FGFR4 extracellular domain inhibits FGF19-induced activation of FGFR4 signaling and prevents nonalcoholic fatty liver disease
- (2011) Qiang Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
- (2011) J. Prawitt et al. DIABETES
- Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study
- (2011) R. M. Williamson et al. DIABETES CARE
- Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis
- (2011) Derrick M. Van Rooyen et al. GASTROENTEROLOGY
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- NASH: A global health problem
- (2011) Arun J. Sanyal HEPATOLOGY RESEARCH
- Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
- (2011) Mitsuhiro Watanabe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glucose homeostasis
- (2011) Xuemei Ge et al. JOURNAL OF LIPID RESEARCH
- Roles of microRNA-29a in the Antifibrotic Effect of Farnesoid X Receptor in Hepatic Stellate Cells
- (2011) J. Li et al. MOLECULAR PHARMACOLOGY
- Bile Acids as Regulators of Hepatic Lipid and Glucose Metabolism
- (2010) Michael Trauner et al. DIGESTIVE DISEASES
- Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis
- (2010) Tiangang Li et al. HEPATOLOGY
- Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease
- (2010) Zhao-Xia Yang et al. Hepatology International
- Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?
- (2010) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist
- (2010) G. Rizzo et al. MOLECULAR PHARMACOLOGY
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
- FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
- (2009) Sabrina Cipriani et al. JOURNAL OF LIPID RESEARCH
- Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
- (2009) Philippe Lefebvre et al. PHYSIOLOGICAL REVIEWS
- Antiatherosclerotic effect of farnesoid X receptor
- (2008) Andrea Mencarelli et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- FXR: a metabolic regulator and cell protector
- (2008) Yan-Dong Wang et al. CELL RESEARCH
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
- (2008) J. Xu et al. DIABETES
- Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes
- (2008) Cédric Langhi et al. FEBS LETTERS
- Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases
- (2008) Sudheer K. Mantena et al. FREE RADICAL BIOLOGY AND MEDICINE
- Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α-hydroxylase gene expression
- (2008) Kwang-Hoon Song et al. HEPATOLOGY
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
- Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet
- (2008) B. Kong et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Targeting bile-acid signalling for metabolic diseases
- (2008) Charles Thomas et al. NATURE REVIEWS DRUG DISCOVERY
- The Role of FXR in Disorders of Bile Acid Homeostasis
- (2008) Jyrki J. Eloranta et al. PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now